TY - JOUR
T1 - Late-breaking Trials from the 2016 American Heart Association's Scientific Sessions
AU - Buchanan, Kyle D.
AU - Alraies, M. Chadi
AU - Kajita, Alexandre H.
AU - Rogers, Toby
AU - Koifman, Edward
AU - Steinvil, Arie
N1 - Publisher Copyright:
© 2016
PY - 2017/1/1
Y1 - 2017/1/1
N2 - The late breaking trials released at the American Heart Association scientific sessions conference in November in New Orleans, LA covered a wide range of topics, including new devices within the field of heart failure, new registry data on transcatheter aortic valve replacement (TAVR) in intermediate risk patients, and medical management of peripheral arterial disease, coronary artery disease, and hypercholesterolemia. The following review highlights the late breaking trials presented at the conference that will have significant impact on clinical practice.
AB - The late breaking trials released at the American Heart Association scientific sessions conference in November in New Orleans, LA covered a wide range of topics, including new devices within the field of heart failure, new registry data on transcatheter aortic valve replacement (TAVR) in intermediate risk patients, and medical management of peripheral arterial disease, coronary artery disease, and hypercholesterolemia. The following review highlights the late breaking trials presented at the conference that will have significant impact on clinical practice.
KW - Atrial fibrillation
KW - Coronary artery disease
KW - Heart failure
KW - Transcatheter aortic valve replacement
UR - http://www.scopus.com/inward/record.url?scp=85010369437&partnerID=8YFLogxK
U2 - 10.1016/j.carrev.2016.12.002
DO - 10.1016/j.carrev.2016.12.002
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 28131332
AN - SCOPUS:85010369437
SN - 1553-8389
VL - 18
SP - 70
EP - 74
JO - Cardiovascular Revascularization Medicine
JF - Cardiovascular Revascularization Medicine
IS - 1
ER -
